Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Veracyte Inc (Veracyte) is a molecular diagnostics company that specializes in genomic testing for cancer diagnosis and treatment. The company’s products include Afirma genomic sequencing classifier for thyroid cancer, Decipher prostate genomic classifier targets prostate cancer; the prosigna breast cancer assay, which treats breast cancer; Decipher bladder genomic classifier targets bladder cancer; Percepta nasal swab test treats lung cancer; and Lymphmark targets diffuse large B-cell lymphoma. Its MRD technology platform delivers high-performing cancer tests by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine. The company operates in the US, the Netherlands, France and Israel. Veracyte is headquartered in San Francisco, California, the US.
Veracyte Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Afirma Genomic Sequencing Classifier: Thyroid Cancer | Percepta |
| Decipher Prostate Genomic Classifier: Prostate Cancer | Prosigna |
| Decipher Bladder Genomic Classifier: Bladder Cancer | Afirma |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Veracyte Inc | Exact Sciences Corp | Natera Inc | Guardant Health Inc | Myriad Genetics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | South San Francisco | Madison | Austin | Palo Alto | Salt Lake |
| State/Province | California | Wisconsin | Texas | California | Utah |
| No. of Employees | 755 | 7,200 | 6,135 | 2,490 | 2,700 |
| Entity Type | Public | Private | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Robert S. Epstein, M.D | Chairman | Executive Board | 2015 | 70 |
| Marc Stapley | Director; Chief Executive Officer | Executive Board | 2021 | 56 |
| Rebecca Chambers | Chief Financial Officer | Senior Management | 2021 | 48 |
| Jonathan Wygant | Chief Accounting Officer | Senior Management | 2022 | - |
| Steven French | Chief Information Officer | Senior Management | 2022 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer